Wave Life Sciences (WVE) Interest Expenses (2014 - 2025)
Wave Life Sciences (WVE) posted Interest Expenses of $2.8 million for Q4 2025, down 98.96% on a QoQ basis from $272.3 million in Q4 2024, and down 98.96% year-over-year from $272.3 million in Q4 2024.
Wave Life Sciences (WVE) Interest Expenses (2014 - 2025) Analysis & Trends
Wave Life Sciences' Interest Expenses history runs 12 years deep, the most recent figure standing at $2.8 million for Q4 2025.
- Quarterly Interest Expenses fell 98.96% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (down 98.96% YoY) and the FY2025 annual result came in at $213.3 million, down 21.69% from the prior year.
- Interest Expenses was $2.8 million for Q4 2025 at Wave Life Sciences, down from $272.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $272.3 million in Q4 2024 and bottomed at $2.8 million in Q4 2025.
- A 5-year average of $197.4 million and a median of $238.2 million in 2021 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses advanced 21.9% — and 2025, when it tumbled 98.96%.
- Wave Life Sciences' Interest Expenses stood at $238.2 million in 2021, then declined by 5.0% to $226.3 million in 2022, then grew by 9.25% to $247.2 million in 2023, then gained by 10.16% to $272.3 million in 2024, then tumbled by 98.96% to $2.8 million in 2025.
- Business Quant data shows WVE's Interest Expenses at $2.8 million in Q4 2025, $272.3 million in Q4 2024, and $247.2 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 272.31 Mn |
| Dec 31, 2024 | 272.31 Mn |
| Dec 31, 2023 | 247.19 Mn |
| Dec 31, 2023 | 247.19 Mn |
| Dec 31, 2022 | 226.27 Mn |
| Dec 31, 2022 | 226.27 Mn |
| Dec 31, 2021 | 238.17 Mn |
| Dec 31, 2021 | 238.17 Mn |
| Dec 31, 2020 | 195.38 Mn |
| Dec 31, 2020 | 195.38 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Sep 30, 2019 | 45.67 Mn |
| Sep 30, 2019 | 45.67 Mn |
| Jun 30, 2019 | 6.02 Mn |
| Jun 30, 2019 | 6.02 Mn |
| Mar 31, 2019 | 1.40 Mn |
| Mar 31, 2019 | 1.40 Mn |